These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21955853)

  • 21. Economic considerations for the eradication endgame.
    Barrett S
    Philos Trans R Soc Lond B Biol Sci; 2013 Aug; 368(1623):20120149. PubMed ID: 23798697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
    Yehualashet YG; Horton J; Mkanda P; Vaz RG; Afolabi O; Gashu SG; Banda R; O'Malley H; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eradicating infectious disease using weakly transmissible vaccines.
    Nuismer SL; Althouse BM; May R; Bull JJ; Stromberg SP; Antia R
    Proc Biol Sci; 2016 Oct; 283(1841):. PubMed ID: 27798311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Socioecological Challenges of Polio Supplementary Immunization Activities (SIAs) in the Asia-Pacific Region: A Systematic Review.
    Ahmad H; Sanef SA; Shahabudin WZ; Mohtar N; Hassan MR; Jeffree MS; Lukman KA; Ghazi HF; Syed Abdul Rahim SS
    J Environ Public Health; 2023; 2023():4801424. PubMed ID: 36747498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.
    Verguet S; Johri M; Morris SK; Gauvreau CL; Jha P; Jit M
    Vaccine; 2015 Mar; 33(10):1291-6. PubMed ID: 25541214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling infectious diseases with herd immunity in a randomly mixed population.
    Law KB; M Peariasamy K; Mohd Ibrahim H; Abdullah NH
    Sci Rep; 2021 Oct; 11(1):20574. PubMed ID: 34663839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the Stop Transmission of Polio (STOP) program in developing countries: the experience of Kenya.
    Tesfaye B; K Makam J; Sergon K; Onuekwusi I; Muitherero C; Sowe A
    BMC Public Health; 2020 Jul; 20(1):1110. PubMed ID: 32664859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Herd immunity": a rough guide.
    Fine P; Eames K; Heymann DL
    Clin Infect Dis; 2011 Apr; 52(7):911-6. PubMed ID: 21427399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poliovirus Studies during the Endgame of the Polio Eradication Program.
    Arita M
    Jpn J Infect Dis; 2017 Jan; 70(1):1-6. PubMed ID: 27795480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
    Duintjer Tebbens RJ; Hampton LM; Thompson KM
    BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expanded programme on immunization: a lasting legacy of smallpox eradication.
    Okwo-Bele JM; Cherian T
    Vaccine; 2011 Dec; 29 Suppl 4():D74-9. PubMed ID: 22486980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new global immunisation vision and strategy.
    Bilous J; Eggers R; Gasse F; Jarrett S; Lydon P; Magan A; Okwo-Bele JM; Salama P; Vandelaer J; Villeneuve P; Wolfson L
    Lancet; 2006 May; 367(9521):1464-6. PubMed ID: 16679143
    [No Abstract]   [Full Text] [Related]  

  • 34. A Collaborative Initiative to Strengthen Sustainable Public Health Capacity for Polio Eradication and Routine Immunization Activities in the Eastern Mediterranean Region.
    Al Gunaid M; Lami F; Jarour N
    JMIR Public Health Surveill; 2019 Oct; 5(4):e14664. PubMed ID: 31663863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Social contact networks and disease eradicability under voluntary vaccination.
    Perisic A; Bauch CT
    PLoS Comput Biol; 2009 Feb; 5(2):e1000280. PubMed ID: 19197342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The progress of the Polio Eradication Initiative: what prospects for eradicating measles?
    Gounder C
    Health Policy Plan; 1998 Sep; 13(3):212-33. PubMed ID: 10187593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
    Prada JM; Metcalf CJE; Takahashi S; Lessler J; Tatem AJ; Ferrari M
    Vaccine; 2017 Mar; 35(11):1488-1493. PubMed ID: 28216186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eradicating and eliminating infectious diseases: past, present and future.
    Narain JP
    Indian J Public Health; 2011; 55(2):81-7. PubMed ID: 21941041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calling the shots: immunization finance policies and practices. Executive summary of the report of the Institute of Medicine.
    Guyer B; Smith DR; Chalk R
    Am J Prev Med; 2000 Oct; 19(3 Suppl):4-12. PubMed ID: 11024319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
    Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.